Episode 74. Peeing in the wind: The Management of UTI in the ED

Share:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Urinary tract Infections

Epidemiology

In the United States, urinary tract infection is the most common bacterial infection. It has about more than 8 million visits yearly. UTI is more common in women in which 50% will experience it in their lifetime. Women are 6 times more affected than men. Antibiotic is its main treatment. 15% of medicines are made for UTI.

Classifications of UTI:

  • Complicated – urinary tract infections are related with a predisposing lesion of the urinary tract; however, this may also refer to all other infections, excluding those in the health, premenopausal adult female.
  • Uncomplicated – is an infection in a healthy, premenopausal female who lacks anatomical or functional deviations of the urinary tract. About 75%-90% of most uncomplicated UTIs are due to Escherichia coli and the rest are due to Staphylococcus saprophyticus, Proteus spp., and Klebsiella spp.

Recurrent UTI are either:

  • Reinfection – occurs more than 2 weeks after the last UTI and recognized as new uncomplicated UTI.
  • Relapse – occurs within 2 weeks of the original infection, and it is considered as a relapse of the original infection. This may be due to unsuccessful treatment of the original infection, structural deviations, or resistant microorganisms.

Etiology

Lower UTI or refer as cystitis is more common in women than in men. The upper UTI is also refer to as pyelonephritis. The common cause of UTI is different bacteria which is specified below:

Complicated UTI may be caused by the following organisms:

  • Gram-negative organisms and
  • Enterococcus faecalis

Uncomplicated UTI may be caused by the following organisms:

  • Escherichia coli
  • Staphylococcus saprophyticus
  • Proteus spp.
  • Klebsiella spp.

Pathophysiology 


Clinical Presentation

Types of UTISigns and Symptoms
Lower UTIDysuria
Urgency
Frequency
Nocturia
Suprapubic heaviness  
Upper UTI  Fever
Nausea
Vomiting
Flank pain  

Risk Factors

UTI also comes with different predisposing factors such as the following:

PATIENTRISK FACTORS
Premenopausal women of any age·         Diabetes
·         Diaphragm use, especially those with spermicide
·         History of UTI or UTI during childhood
·         Mother or female relatives with history of UTIs
·         Sexual intercourse
Postmenopausal and older adult women·         Estrogen deficiency
·         Functional or mental impairment
·         History of UTI before menopause
·         Urinary catheterization
·         Urinary incontinence
Men and women with structural abnormalities·         Extrarenal obstruction associated with congenital anomalies of the ureter or urethra, calculi, extrinsic ureteral compression, or benign prostate hypertrophy
·         Intrarenal obstruction associated with nephrocalcinosis, uric acid nephropathy, polycystic kidney disease, hypokalemic or analgesic nephropathy, renal lesions from sickle cell disease

Diagnostics

Laboratory TestsImplications
 Urine Analysis  is often used to determine UTIs, and a clean-catch dipstick leukocyte esterase test is a rapid screening test for detecting pyuria with a high sensitivity and specificity for detecting more than 10 WBC/mm3 in urine (Sobel 2014).
Urine Cultureis not suggested for treating acute uncomplicated cystitis. However, for acute pyelonephritis and any type of complicated UTIs, a urine culture should be conducted before empirical therapy to maximize the subsequent specific antibiotic therapy once the susceptible results are obtained.
Basic metabolic panel  A basic metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, and kidney function. Glucose is a type of sugar your body uses for energy. Electrolytes keep your body’s fluids in balance.
Complete blood count  For upper urinary tract infection, CBC is required by most physician to determine if the infection has not spread to your blood stream.

Treatment

CategoryProbable OrganismsRegimenDuration of Therapy
Asymptomatic bacteriuria   Positive culture ≥ 100,000 cfu/ml with or without pyuria but without signs and symptoms This should not be treated in pregnant patients Those who are undergoing urologic procedure in which mucosal bleeding may occurNeutropenic
o   Uncomplicated o   Cystitis   Signs or symptoms (frequency, urgency, dysuria, suprapubic pain) PLUS pyuria (>10 WBC/hpf) PLUS positive urine culture ≥ 100,000 Uncomplicated = non-pregnant females, no urologic abnormalities, no stones, no catheterE. coli1st Line therapy • Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 5 days OR • Trimethoprim-sulfamethoxazole 160/800 mg 1 tablet BID x 3 days (avoid if local resistance > 20%) OR • Fosfomycin trometamol 3-gram single dose   2nd Line therapy • Fluoroquinolones: ciprofloxacin 250 mg BID x 3 days, levofloxacin 250 mg daily x 3 days OR • Guidelines and FDA recommend reserving for other uses than acute uncomplicated cystitis   Beta-lactams (e.g., amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime) 3-7 days of treatment • Studies have shown beta-lactams to be less effective than TMP-SMX or fluoroquinolones
o   Uncomplicated o  PyelonephritisE. coliPyelonephritis (Discharging home from ED)First Line therapy • Fluoroquinolones – Ciprofloxacin 500 mg BID x 7 days – Levofloxacin 750 mg daily x 5 days • TMP-SMX 1 tablet BID x 14 days • Beta-Lactams – Amoxicillin-clavulanate 875/125 mg 1 tablet BID x 14 days – Cefpodoxime 200 mg BID x 14 days • Dosing also dependent upon renal function
Complicated Signs or symptoms (frequency, urgency, dysuria, suprapubic pain) PLUS pyuria (>10 WBC/hpf) PLUS positive urine culture ≥ 100,000 Complicated = male, possible stones, urologic abnormalities, neurogenic bladder * Gonorrhea and Chlamydia should be suspected in a sexually active male with a UTI (refer to Grady STD Guidelines for treatment options)E. coliFirst Line: Cefuroxime 500 mg PO q12h   Second Line: Ciprofloxacin 500 mg PO q12h7 days
·         Urinary Tract Infection in Men ·         Prostatitis  E. coli, but the spectrum of pathogens is more variable for CBP, including E. coli, E. faecalis, K. pneumoniae, P. mirabilis, P. aeruginosa, S. aureus, and streptococcal spp. (Grabe 2015).  The presence of fever with symptoms of cystitis in men may indicate acute bacterial prostatitis (ABP).   When symptoms persist for more than 3 months, chronic bacterial prostatitis (CBP) occurs. Most men with CBP have a condition called chronic pelvic pain syndrome. Four main symptoms of CBP and chronic pelvic pain syndrome are urogenital pain, lower urinary tract symptoms including voiding or storage symptoms, psychological issues, and sexual dysfunction (Rees 2015).7 days
·         Urinary Tract Infection in Pregnancy    E. coliPregnant women should have the treatment for UTI even if they asymptomatic   • Urine culture with ≥ 105 CFU/mL (≥ 104 CFU/mL if group B Streptococcus)   -Outpatient therapy • Nitrofurantoin (Class B) • Beta-Lactams (Class B) -Inpatient therapy • Ceftriaxone (Class B) • Cefepime (Class B) – reserve for history of previous resistance • Piperacillin-Tazobactam (Class B) – reserve for history of previous resistance5 Days
·         Catheterized Patients   Patients with urinary catheter is prone to acquire bacteria that may lead to UTI.  Proteus spp., M. morganii, and P. stuartiiIndividuals symptomatic with CA-UTI are treated similarly to those with acute complicated cystitis in the absence of upper tract symptoms or complicated pyelonephritis if upper tract symptoms are present (Sobel 2014) A urine culture should be obtained before initiation of antibiotic therapy, if possible, from a newly placed catheter because the bacterial less useful (Hooton 2010). In addition, an indwelling catheter that has been in place for 7 days or longer should be removed or replaced before initiating antibiotics (Grabe 2015).5-7 days

ABOUT AUTHOR

Jimmy L. Pruitt III, PharmD, BCPS, BCCCP

The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. To empower healthcare providers with the knowledge and skills they need to provide evidence-based, safe care for critically ill patients.

Posted On

By

Categories

Share

Share on facebook
Share on twitter
Share on linkedin

Subscribe to our Newsletter

New Episodes on 1st, 2nd, 4th Tuedays

Stay Connected to Get The Latest Podcast Alerts

Want to learn more?

Pharmacy and Acute Care University

An e-learning platform that empowers healthcare providers with knowledge and skills so they can provide evidence-based, safe care for these types of patients.

Pin It on Pinterest

%d bloggers like this: